Complizen Learn

IMDRF is the global forum harmonizing medical device regulations across major markets (FDA, MHRA, Health Canada, EU). On Jan, 2025, IMDRF finalized N88 (10 Good Machine Learning Practice principles for AI/ML devices) and N81 (characterization considerations for medical-device software and software-specific risk). IMDRF documents guide—but don’t replace—jurisdictional rules; adoption timing varies by regulator. This guide covers everything you need to know about IMDRF's impact

Medical device companies expanding globally face a critical strategic decision: which regulatory pathway offers the fastest, most cost-effective route to market? EU MDR typically requires 12-18 months and $500K-$2M for CE marking through Notified Body assessment, while FDA 510(k) averages 6-12 months and $1M-$6M but offers faster market access. EU MDR provides broader global market acceptance (27 EU countries + many international markets), while FDA 510(k) is primarily US-foc

Medical device startups have 8 primary funding sources: government grants ($305K-$3M, non-dilutive), angel investors ($50K-$2M, 10-25% equity), venture capital ($1M-$100M+, 15-30% equity per round), crowdfunding ($50K-$1M, variable terms), accelerators ($25K-$250K + mentorship), corporate partnerships, revenue-based financing, and bootstrapping. The smart play is sequencing: validate with grants, bridge with angels, then scale with venture—layering in partnerships or revenue-

A medical device Quality Management System (QMS) proves you can consistently design, make, and support safe, effective devices. It's required for market approval in virtually every major jurisdiction and serves as your roadmap for avoiding costly mistakes, recalls, and regulatory delays. In the U.S., FDA will replace QSR (21 CFR 820) with QMSR on Feb 2, 2026, incorporating ISO 13485:2016 by reference. Globally, ISO 13485 remains the baseline. FDA does not require ISO 13485 ce

A Predetermined Change Control Plan (PCCP) is FDA documentation that lets you pre-define specific AI/ML software changes—and the methods to develop, validate, implement, and monitor them—so those updates can be made without a new marketing submission, when executed exactly as an authorized PCCP. PCCPs include three components: Description of Modifications, Modification Protocol, and Impact Assessment. Available for 510(k), De Novo, and PMA pathways for AI-enabled device softw

FDA consensus standards are voluntary international standards that FDA recognizes for medical device submissions. Companies can submit a Declaration of Conformity (DOC) to demonstrate compliance with recognized standards, potentially reducing testing documentation and accelerating FDA review. Over 1,800 standards are currently recognized across safety, biocompatibility, software, and performance categories. Always verify the recognized edition and extent of recognition in FDA